Global Breast Implant Market Estimated to Surpass $4.9 Billion by 2026, and Grow at a CAGR of 10.3% during the Forecast Period [170-Pages] | Divulge by Research Dive
January 03, 2022 09:00 ET
|
Research Dive
New York, USA, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Research Dive states that the global breast implant market is estimated to garner a revenue of $4.9 billion by 2026, and rise at a CAGR of 10.3% in...
Global Breast Implant Market Projected to Beat $4.9 Billion, Growing at 10.3% CAGR from 2019 to 2026 [170-Pages] | Exclusively available on Research Dive
December 01, 2021 09:45 ET
|
Research Dive
New York, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- A new report on the global breast implant market has been added by Research Dive to its repository. According to the report, the global market is...
Global Breast Implant Market Predicted to Garner $4.9 Billion by 2026 at a CAGR of 10.3% from 2019-2026 - Exclusive Report [170-Pages] by Research Dive
September 22, 2021 09:00 ET
|
Research Dive
New York, USA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- A recently published report by Research Dive states that the global breast implant market is anticipated to garner revenue of $4.9 Billion by...
TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB
December 29, 2016 10:30 ET
|
TetraLogic Pharmaceuticals
PAOLI, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”) and its wholly-owned subsidiary TetraLogic Research and Development...
TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock
November 02, 2016 16:30 ET
|
TetraLogic Pharmaceuticals
PAOLI, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”), a clinical-stage biopharmaceutical company focused on discovering and...
Biotricity to Demonstrate Its IoT Medical Device at AT&T’s Shape
July 05, 2016 08:30 ET
|
Biotricity
REDWOOD CITY, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- WHO: Biotricity,...
SHAPE Task Force Reflects on 10 Years of Progress Toward Heart Attack Eradication
August 17, 2015 07:00 ET
|
SHAPE
LOS ANGELES, Aug. 17, 2015 (GLOBE NEWSWIRE) -- SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the...
Six Additional East Texas Medical Center Hospitals Certified as SHAPE Centers of Excellence
August 06, 2015 06:00 ET
|
SHAPE
HOUSTON, Aug. 6, 2015 (GLOBE NEWSWIRE) -- SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the mission of...
TetraLogic Announces Update on MDS Clinical Program
June 30, 2015 16:01 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., June 30, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
SHAPE Applauds U.S Preventive Services Task Force for Seeking the Truth About Coronary Artery Calcium
June 24, 2015 09:36 ET
|
SHAPE
HOUSTON, June 24, 2015 (GLOBE NEWSWIRE) -- SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the mission of...